National Home Infusion Association

Take 1 minute to share your support for home infusion legislation! Momentum has been building for legislators to address Medicare’s home infusion benefit as part of a year-end legislative package. After considerable engagement from NHIA, the groundwork has been laid for Congress to pass the Preserving Patient Access to Home Infusion Act (H.R. 4104; S. 1976) and enhance access to home infusion services for Medicare beneficiaries nationwide. TAKE ACTION: https://loom.ly/Q9JhnA8

Meet our NHIA 2025 speakers! We asked our content experts to share highlights on their conference session(s) as well as other interests so you can get to know these amazing professionals better. We will continue to share more profiles on speakers and their content as we approach the conference. https://loom.ly/kUGD4tE

Join Connie Sullivan, NHIA President & CEO, Shea McCarthy, Director of Legislative Affairs, and Bill Noyes, NHIA Sr VP of Reimbursement Policy for a Talk Infusion webinar reviewing the 2024 end of year government funding on health care policies and what lies ahead for the next Congress. NHIA will also provide an update on the implementation of the Medicare Prescription Payment Plan (MPPP) and Maximum Fair Price (MFP) provisions of the Inflation Reduction Act. Register: https://loom.ly/OcQxm_w

Early bird pricing ends Wednesday, January 8! Don't miss your chance to save on NHIA 2025 conference registration and make the year's best investment! Learn more & register: https://loom.ly/dOEtkZw

Shane Bare is a patient who takes immune globulin to keep his chronic inflammatory demyelinating polyneuropathy (CIDP) from progressing. Despite being in a wheelchair due to a spinal cord injury, Bare is very independent, administering his therapy subcutaneously at home each week. He had to fight many battles to get Medicare to cover his life-saving therapy and has harnessed that energy into advocating for home infusion patients and coverage of services in the site of care that works best for the patient. Watch the video: https://loom.ly/xKizYDw

NHIA's 2020 Infusion Industry Trends is a guide to understanding the U.S. home and specialty infusion market and outlines key metrics on how the industry has evolved since 2010. This report connects 227 data points and provides valuable business intelligence with a deep dive into the industry's status pre-pandemic. This report, while published originally in 2020 provides invaluable background about how the benefit functions within the U.S. health care system. NHIA has plans to publish an updated report with a focus on how the industry has evolved since the pandemic with regard to impacted access and utilization of infusion therapies.  Download a free copy: https://loom.ly/2UGo1DU

NHIA expressed deep concern today regarding the recently proposed government funding bill, which includes major changes to the qualifying criteria for drugs under Medicare’s home infusion benefit but fails to address the underlying flaws that have plagued the program. Without fixing the structure of the benefit, Medicare beneficiaries in need of home infusions for treatment of a variety of medical conditions, including rare diseases, are unlikely to gain access to home-based care. NHIA is calling on Congress to urgently pass the Preserving Patient Access to Home Infusion Act, which would fix the broken home infusion benefit, reduce the cost of care, and broaden access. This bipartisan legislation — which enjoys support from dozens of stakeholder organizations and was widely supported at a hearing in the House Ways & Means Committee this year — includes critical reforms that will ensure beneficiaries living in rural areas and those with disabilities who depend on home access can find a qualified provider. Read more: https://loom.ly/HYv4BEQ

Congratulations to Integrated Medical Systems, Inc. on 30 years in the alternate site market! NHIA appreciates your partnership as one of our FIAC members and the care you take to shine a light on the people and innovation that make this care model so unique. Cheers to many more successful years!

NHIA member Glenel Tillich entered home infusion reimbursement in 1989 with no background in medical billing. An amazing mentor taught her the complex ins and outs of managing outstanding AR from billing to claims adjudication—in an all-manual system. Now she leads a company that provides revenue management services to provider clients. Over the years, Tillich has developed a passion for home infusion, noting that “the outcomes are better, compliance is better, and it makes for a healthier for patient all around.” Watch the video: https://loom.ly/LzBJCts Glenel Tillich, FNHIA President TANYR

With the growing use of subcutaneous products in the home infusion setting, billing for these items can be a challenge for the home infusion revenue cycle professional as it differs from traditional IV billing processes. Join NHIA for an Operations Elevation webinar on Dec. 18 that will review key considerations and provide tips for effectively and accurately billing for subcutaneous drug administration. Learn more & register: https://loom.ly/bQNKLkQ The 2024 Operations Elevation series is supported through an unrestricted education grant by Managed Health Care Associates, Inc. (MHA) and we thank them for their ongoing support.